Organogenesis Holdings Inc (ORGO)
2.345
+0.06
(+2.63%)
USD |
NASDAQ |
Apr 26, 16:00
2.345
0.00 (0.00%)
After-Hours: 19:53
Organogenesis Holdings Profit Margin (Quarterly): -0.57% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.57% |
| September 30, 2023 | 2.92% |
| June 30, 2023 | 4.53% |
| March 31, 2023 | -2.76% |
| December 31, 2022 | 6.48% |
| September 30, 2022 | 0.18% |
| June 30, 2022 | 7.20% |
| March 31, 2022 | -0.94% |
| December 31, 2021 | 39.88% |
| September 30, 2021 | 11.06% |
| June 30, 2021 | 16.79% |
| March 31, 2021 | 9.70% |
| December 31, 2020 | 17.15% |
| September 30, 2020 | 20.59% |
| June 30, 2020 | -7.49% |
| Date | Value |
|---|---|
| March 31, 2020 | -26.43% |
| December 31, 2019 | -3.55% |
| September 30, 2019 | -16.71% |
| June 30, 2019 | -14.86% |
| March 31, 2019 | -27.42% |
| December 31, 2018 | -14.55% |
| September 30, 2018 | -25.76% |
| June 30, 2018 | -45.95% |
| March 31, 2018 | -63.29% |
| December 31, 2017 | -3.42% |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | -12.22% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-26.43%
Minimum
Mar 2020
39.88%
Maximum
Dec 2021
3.32%
Average
2.92%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.82% |
| Return on Assets | 1.09% |
| Return on Invested Capital | 1.46% |
| Gross Profit Margin (Quarterly) | 72.13% |
| Operating Margin (Quarterly) | -1.27% |
| Return on Net Operating Assets | 1.53% |